Tag Archives: REGN

Top 10 Stocks To Own Right Now

Virginia Retirement Systems ET AL acquired a new position in Olin Co. (NYSE:OLN) in the 1st quarter, HoldingsChannel reports. The firm acquired 11,800 shares of the specialty chemicals company’s stock, valued at approximately $359,000.

Several other institutional investors also recently modified their holdings of OLN. Bessemer Group Inc. raised its stake in shares of Olin by 971.4% in the fourth quarter. Bessemer Group Inc. now owns 4,725 shares of the specialty chemicals company’s stock worth $168,000 after purchasing an additional 4,284 shares during the last quarter. Fuller & Thaler Asset Management Inc. purchased a new stake in shares of Olin during the fourth quarter valued at approximately $178,000. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of Olin during the fourth quarter valued at approximately $201,000. Atria Investments LLC purchased a new stake in shares of Olin during the first quarter valued at approximately $201,000. Finally, Naples Global Advisors LLC purchased a new stake in shares of Olin during the fourth quarter valued at approximately $206,000. 89.02% of the stock is owned by hedge funds and other institutional investors.

Top 10 Stocks To Own Right Now: Aerohive Networks, Inc.(HIVE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Aerohive Networks Inc (NYSE:HIVE) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 573,420 shares, a drop of 35.3% from the May 31st total of 885,671 shares. Based on an average trading volume of 381,201 shares, the days-to-cover ratio is currently 1.5 days. Approximately 1.8% of the shares of the stock are short sold.

  • [By Max Byerly]

    Leidos (NYSE: LDOS) and Aerohive Networks (NYSE:HIVE) are both aerospace companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

  • [By Stephan Byrd]

    Here are some of the news articles that may have effected Accern’s rankings:

    Get Anthera Pharmaceuticals alerts:

    Cystic Fibrosis Drugs Market – Future Growth Prospects and Industry Trends Analyzed Till 2025 (digitaljournal.com) Analysts Anticipate Anthera Pharmaceuticals Inc (ANTH) Will Announce Earnings of -$0.60 Per Share (americanbankingnews.com) News Buzz : Blink Charging Co. (NASDAQ:BLNK), Genocea Biosciences, Inc. (NASDAQ:GNCA), Anthera … (journalfinance.net) Current Lumpy Stocks:: Jounce Therapeutics, Inc. (NASDAQ:JNCE), Aerohive Networks, Inc. (NYSE:HIVE), Anthera … (journalfinance.net) Porous, non-porous tantalum cups yielded similar septic, aseptic risks after revision THA (healio.com)

    ANTH has been the topic of a number of research analyst reports. Zacks Investment Research upgraded Anthera Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Tuesday, February 13th. Jefferies Financial Group reiterated a “hold” rating and set a $0.50 target price on shares of Anthera Pharmaceuticals in a research report on Thursday, March 15th. Roth Capital initiated coverage on Anthera Pharmaceuticals in a research report on Wednesday, February 21st. They set a “buy” rating and a $10.00 target price on the stock. Finally, Piper Jaffray Companies downgraded Anthera Pharmaceuticals from an “overweight” rating to an “underweight” rating in a research report on Monday, March 12th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $3.44.

Top 10 Stocks To Own Right Now: Tree.com Inc.(TREE)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market climbed sharply on Thursday, responding well to favorable earnings results from several corners of the market. Major benchmarks were up 1% to 2%, with particularly good performance from the Nasdaq Composite thanks to the tech sector’s outperformance during the day. Yet some stocks suffered from bad news that cast doubt on companies’ ability to benefit from generally favorable business conditions. MGM Resorts International (NYSE:MGM), Arch Coal (NYSE:ARCH), and LendingTree (NASDAQ:TREE) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Logan Wallace]

    Rhumbline Advisers decreased its position in LendingTree (NASDAQ:TREE) by 13.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,988 shares of the financial services provider’s stock after selling 2,252 shares during the period. Rhumbline Advisers’ holdings in LendingTree were worth $4,590,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Logan Wallace]

    Gabelli Funds LLC trimmed its position in shares of LendingTree (NASDAQ:TREE) by 2.9% during the first quarter, Holdings Channel reports. The institutional investor owned 8,450 shares of the financial services provider’s stock after selling 250 shares during the period. Gabelli Funds LLC’s holdings in LendingTree were worth $2,773,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    These are some of the media headlines that may have effected Accern’s rankings:

    Get LendingTree alerts:

    Zacks: Brokerages Expect LendingTree (TREE) to Post $1.24 EPS (americanbankingnews.com) Form 4/A LendingTree, Inc. For: Apr 12 Filed by: LEBDA DOUGLAS R (streetinsider.com) Form 4/A LendingTree, Inc. For: May 08 Filed by: LEBDA DOUGLAS R (streetinsider.com) LendingTree to acquire Ovation Credit for $20.75 million (wraltechwire.com) LendingTree to buy credit-service provider (mpamag.com)

    LendingTree opened at $271.05 on Wednesday, Marketbeat.com reports. The company has a market capitalization of $3.49 billion, a P/E ratio of 89.75, a price-to-earnings-growth ratio of 2.15 and a beta of 1.77. LendingTree has a 12-month low of $269.95 and a 12-month high of $278.10. The company has a current ratio of 3.33, a quick ratio of 3.33 and a debt-to-equity ratio of 0.73.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Lendingtree (TREE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Lendingtree (TREE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Own Right Now: Regeneron Pharmaceuticals, Inc.(REGN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Regeneron Pharmaceuticals Inc (NASDAQ:REGN) major shareholder Sanofi sold 121,601 shares of Regeneron Pharmaceuticals stock in a transaction dated Friday, June 8th. The stock was sold at an average price of $309.31, for a total value of $37,612,405.31. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

  • [By Cory Renauer]

    The tumor suppressor protein tries to cut out inserted genes, but most of the drugs these companies are developing take a relatively simple disruptive approach. Editas’ lead program, EDIT-101 for the treatment of Leber Congenital Amaurosis snips out a little section of DNA that allows a sight-related gene to be expressed normally, but it doesn’t add anything. Intellia and its partner Regeneron (NASDAQ:REGN) intend to disrupt the production of transthyretin by snipping out a section of DNA without replacing anything either.

  • [By Stephan Byrd]

    Aperio Group LLC boosted its stake in Regeneron (NASDAQ:REGN) by 5.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 26,287 shares of the biopharmaceutical company’s stock after buying an additional 1,330 shares during the period. Aperio Group LLC’s holdings in Regeneron were worth $9,052,000 as of its most recent SEC filing.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Friday was Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) which rose about 7.5% to $310.61. The stocks 52-week range is $281.89 to $543.55. Volume was 2.8 million compared to the daily average volume of nearly 1 million.

Top 10 Stocks To Own Right Now: Motorola Solutions, Inc.(MSI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Norinchukin Bank The boosted its stake in shares of Motorola Solutions Inc (NYSE:MSI) by 16.8% during the first quarter, HoldingsChannel.com reports. The firm owned 15,755 shares of the communications equipment provider’s stock after purchasing an additional 2,263 shares during the quarter. Norinchukin Bank The’s holdings in Motorola Solutions were worth $1,659,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Peter Graham]

    A long term performance chart shows Qualcomm breaking even whilepotential peers Cisco Systems, Inc (NASDAQ: CSCO) and Motorola Solutions Inc (NYSE: MSI) have performed better with theirheir share of volatility:

  • [By Shane Hupp]

    Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp lowered its holdings in Motorola Solutions Inc (NYSE:MSI) by 4.6% in the 1st quarter, HoldingsChannel.com reports. The firm owned 434,200 shares of the communications equipment provider’s stock after selling 20,800 shares during the quarter. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp’s holdings in Motorola Solutions were worth $45,721,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Element Capital Management LLC acquired a new position in Motorola Solutions Inc (NYSE:MSI) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 98,736 shares of the communications equipment provider’s stock, valued at approximately $10,397,000.

  • [By Joseph Griffin]

    Morneau Shepell Inc (TSE:MSI) declared a monthly dividend on Tuesday, June 19th, Zacks reports. Investors of record on Friday, June 29th will be given a dividend of 0.065 per share on Monday, July 16th. This represents a $0.78 annualized dividend and a dividend yield of 2.85%. The ex-dividend date of this dividend is Thursday, June 28th.

Top 10 Stocks To Own Right Now: Invesco Credit Opportunities Fund(VTA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Headlines about Invesco Dynamic Credit Opportunities Fd (NYSE:VTA) have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Invesco Dynamic Credit Opportunities Fd earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned press coverage about the investment management company an impact score of 46.2340823797619 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Top 10 Stocks To Own Right Now: Chemical Financial Corporation(CHFC)

Advisors’ Opinion:

  • [By Max Byerly]

    Chemical Financial (NASDAQ: CHFC) and Macatawa Bank (NASDAQ:MCBC) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability and risk.

  • [By Max Byerly]

    Envestnet Asset Management Inc. boosted its stake in Chemical Financial Co. (NASDAQ:CHFC) by 60.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,192 shares of the bank’s stock after purchasing an additional 6,123 shares during the period. Envestnet Asset Management Inc.’s holdings in Chemical Financial were worth $884,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Media stories about Chemical Financial (NASDAQ:CHFC) have been trending somewhat positive recently, Accern reports. Accern ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Chemical Financial earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned news articles about the bank an impact score of 45.6707430515367 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Stocks To Own Right Now: P.T. Telekomunikasi Indonesia Tbk.(TLK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tuesday afternoon, the telecommunication services shares climbed 1.18 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 7 percent, and Telekomnks Indn Prsr Tbk Prshn Prsrn-ADR (NYSE: TLK), up 3 percent.

  • [By Anders Bylund]

    Telekomunikasi Indonesia (NYSE:TLK), the largest telecommunications company in Indonesia, reported first-quarter results on Tuesday, May 2. Top-line sales rose modestly in the first quarter thanks to higher wireless subscriber counts and a healthy broadband business, but those upsides had to overcome a substantial headwind from a mass exodus of old-school wireline subscribers.

  • [By Max Byerly]

    Telekomnks Indn Prsr Tbk Prshn Prsrn (NYSE:TLK) was upgraded by equities research analysts at Macquarie from a “neutral” rating to an “outperform” rating in a research report issued to clients and investors on Wednesday, The Fly reports.

Top 10 Stocks To Own Right Now: DBV Technologies S.A.(DBVT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on DBV Technologies (DBVT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Shares of DBV Technologies (NASDAQ:DBVT) have earned a consensus recommendation of “Hold” from the twelve research firms that are currently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating on the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $44.00.

  • [By Max Byerly]

    Shares of DBV Technologies (NASDAQ:DBVT) hit a new 52-week low on Tuesday . The stock traded as low as $20.00 and last traded at $20.31, with a volume of 2187 shares trading hands. The stock had previously closed at $20.07.

Top 10 Stocks To Own Right Now: First Cash Financial Services, Inc.(FCFS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    First Cash Financial Services (NYSE: FCFS) and Ferrellgas Partners (NYSE:FGP) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, valuation, earnings, risk, analyst recommendations and profitability.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on First Cash Financial Services (FCFS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    First Cash Financial Services, Inc. (NYSE:FCFS) shares hit a new 52-week high and low during trading on Thursday . The company traded as low as $88.95 and last traded at $88.70, with a volume of 371494 shares traded. The stock had previously closed at $87.80.

  • [By Shane Hupp]

    FirstCash (NYSE: FCFS) and CafePress (NASDAQ:PRSS) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends.

Top 10 Stocks To Own Right Now: United States Cellular Corporation(USM)

Advisors’ Opinion:

  • [By Logan Wallace]

    These are some of the media stories that may have impacted Accern Sentiment Analysis’s analysis:

    Get U.S. Cellular alerts:

    $962.41 Million in Sales Expected for U.S. Cellular (USM) This Quarter (americanbankingnews.com) $0.21 Earnings Per Share Expected for U.S. Cellular (USM) This Quarter (americanbankingnews.com) OneNeck IT Solutions named to CRNs 2018 Solution Provider 500 list (prweb.com) U.S. Cellular Unveils Offers on iPhones With New Connections (zacks.com)

    USM has been the subject of several research analyst reports. Raymond James raised shares of U.S. Cellular from a “market perform” rating to an “outperform” rating in a research report on Wednesday, May 2nd. ValuEngine raised shares of U.S. Cellular from a “sell” rating to a “hold” rating in a research report on Monday, April 2nd. Finally, Zacks Investment Research raised shares of U.S. Cellular from a “hold” rating to a “buy” rating and set a $41.00 price objective for the company in a research report on Tuesday, February 27th.

  • [By Ethan Ryder]

    NII (NASDAQ: NIHD) and U.S. Cellular (NYSE:USM) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, profitability and dividends.

  • [By Max Byerly]

    JPMorgan Chase & Co. raised its holdings in U.S. Cellular (NYSE:USM) by 770.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 52,229 shares of the Wireless communications provider’s stock after acquiring an additional 46,231 shares during the period. JPMorgan Chase & Co. owned about 0.06% of U.S. Cellular worth $2,099,000 at the end of the most recent quarter.

Top 5 Undervalued Stocks To Own For 2019

Sonic Drive-In (NASDAQ:SONC) declared that its Board of Directors has initiated a share repurchase program, which allows the company to buyback $500.00 million in shares on Thursday, July 12th. This buyback authorization allows the restaurant operator to buy up to 39.6% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s management believes its stock is undervalued.

A number of equities analysts have issued reports on SONC shares. Telsey Advisory Group restated a “market perform” rating and set a $28.00 target price (down previously from $31.00) on shares of Sonic Drive-In in a research report on Wednesday, March 14th. Zacks Investment Research cut shares of Sonic Drive-In from a “buy” rating to a “hold” rating in a research report on Thursday, March 15th. Wells Fargo & Co cut their target price on shares of Sonic Drive-In from $30.00 to $27.00 and set a “market perform” rating for the company in a research report on Monday, March 19th. BidaskClub upgraded shares of Sonic Drive-In from a “sell” rating to a “hold” rating in a research report on Tuesday, March 20th. Finally, Morgan Stanley cut their target price on shares of Sonic Drive-In from $29.00 to $28.00 and set an “equal weight” rating for the company in a research report on Monday, March 26th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and six have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $31.36.

Top 5 Undervalued Stocks To Own For 2019: Celldex Therapeutics Inc(CLDX)

Advisors’ Opinion:

  • [By George Budwell]

    Shares of Celldex Therapeutics (NASDAQ:CLDX), a small-cap cancer company, are down by over 43% in pre-market trading today on extremely heavy volume. What’s going on?

  • [By Stephan Byrd]

    Celldex Therapeutics (NASDAQ: CLDX) and Immunomedics (NASDAQ:IMMU) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings.

  • [By Paul Ausick]

    Celldex Therapeutics Inc. (NASDAQ: CLDX) traded down less than 0.11% Tuesday to post a new 52-week low of $0.65 after closing Monday at $0.66. The stock’s 52-week high is $3.26. Volume was about 30% above the daily average of around 2.9 million shares. The company had no specific news.

Top 5 Undervalued Stocks To Own For 2019: Regeneron Pharmaceuticals, Inc.(REGN)

Advisors’ Opinion:

  • [By ]

    Celgene (CELG) : “I’d rather buy Amgen (AMGN) or Regeneron Pharmaceuticals (REGN) . I think Celgene overpaid for that acquisition a few years ago.”

  • [By Todd Campbell, Keith Speights, and Brian Feroldi]

    Biotechnology stocks can pop or drop because of clinical trial successes or failures, and that makes investing in biotech stocks riskier than investing in other industries. Nevertheless, the rewards for those biotech companies that successfully innovate new therapies can be significant, and that makes stocks like Regenxbio (NASDAQ:RGNX), Regeneron Pharmaceuticals (NASDAQ:REGN), and AbbVie (NYSE:ABBV) worth considering. Read on to learn more about these companies and why some of our Motley Fools think they could be top stocks to add to portfolios this month.

  • [By Todd Campbell]

    When a brand new class of cholesterol-lowering drugs called PCSK9 inhibitors won Food and Drug Administration (FDA) approval in 2015, it was heralded as the biggest advance in battling heart disease since the invention of statins. The launch of PCSK9 inhibitors was accompanied by billion-dollar-plus predictions for sales. However, revenue has fallen far shy of blockbuster status, leaving drugmakers Amgen Inc. (NASDAQ:AMGN), Regeneron Pharmaceuticals (NASDAQ:REGN), and Sanofi SA (NYSE:SNY) in the lurch.

  • [By Joseph Griffin]

    State of Tennessee Treasury Department trimmed its position in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) by 18.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 18,542 shares of the biopharmaceutical company’s stock after selling 4,152 shares during the quarter. State of Tennessee Treasury Department’s holdings in Regeneron Pharmaceuticals were worth $6,385,000 at the end of the most recent reporting period.

  • [By Cory Renauer]

    Attention bargain shoppers: There could be some deals in aisle biotech.Agenus Inc.(NASDAQ:AGEN)andRegeneron Pharmaceuticals (NASDAQ:REGN) dished out some disappointing losses in recent months, but the market’s reaction to recent events seems a bit overdone.

Top 5 Undervalued Stocks To Own For 2019: Dillard's, Inc.(DDS)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    In this episode of Industry Focus: Consumer Goods, Vincent Shen and senior Motley Fool contributor Adam Levine-Weinberg dive into the latest developments fromMacy’s(NYSE:M), Kohl’s(NYSE:KSS), and Dillard’s(NYSE:DDS), which have all enjoyed bullish rallies of 30% in the past month.

  • [By Lisa Levin] Gainers
    SenesTech, Inc. (NASDAQ: SNES) shares jumped 113.5 percent to $0.6737 after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California.
    AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares rose 35.34 percent to close at $3.32.
    Art's-Way Manufacturing Co., Inc. (NASDAQ: ARTW) shares gained 30.36 percent to $3.65.
    Xtant Medical Holdings, Inc. (NYSE: XTNT) shares jumped 25.6 percent to $7.4701 after the company disclosed that it has received the FDA clearance for InTice™-C Porous Titanium Cervical Interbody System.
    VAALCO Energy, Inc. (NYSE: EGY) shares surged 20 percent to $2.495.
    TransGlobe Energy Corporation (NASDAQ: TGA) surged 17.04 percent to $2.61.
    Boxlight Corporation (NASDAQ: BOXL) gained 15 percent to $8.32 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the development of next generation interactive educational activities.
    Arcimoto, Inc. (NASDAQ: FUV) gained 15 percent to $3.39.
    MB Financial, Inc. (NASDAQ: MBFI) rose 13.7 percent to $49.64. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    FRONTEO, Inc. (NASDAQ: FTEO) shares rose 11.8 percent to $20.956.
    TransEnterix, Inc. (NYSE: TRXC) shares jumped 11.1 percent to $3.38.
    21Vianet Group, Inc. (NASDAQ: VNET) rose 10.6 percent to $7.41.
    NII Holdings, Inc. (NASDAQ: NIHD) shares gained 9 percent to $2.32.
    Kelly Services, Inc. (NASDAQ: KELYA) rose 7.6 percent to $24.19. Northcoast Research upgraded Kelly Services from Neutral to Buy.
    LaSalle Hotel Properties (NYSE: LHO) shares climbed 5.6 percent to $33.70. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Alteryx, Inc. (NYSE: AYX) gained 5.5 percent to $32.56. KeyBanc upgraded Alteryx from Sector Weight to Overweight.
    Energizer Holdings, Inc. (NYSE:
  • [By Adam Levine-Weinberg]

    A day later, Macy’s smaller rival Dillard’s (NYSE:DDS) followed with its own solid earnings report. The better-than-expected results and a recent analyst upgrade have helped power a roughly 13% rally in Dillard’s stock over the past week.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Walmart Inc. (NYSE: WMT) is estimated to report quarterly earnings at $1.13 per share on revenue of $120.51 billion.
    J. C. Penney Company, Inc. (NYSE: JCP) is expected to report quarterly loss at $0.2 per share on revenue of $2.63 billion.
    Dillard's, Inc. (NYSE: DDS) is projected to report quarterly earnings at $2.77 per share on revenue of $1.46 billion.
    The Children's Place, Inc. (NASDAQ: PLCE) is estimated to report quarterly earnings at $2.21 per share on revenue of $444.14 million.
    Manchester United plc (NYSE: MANU) is expected to report quarterly loss at $1.35 per share on revenue of $193.67 million.
    Teekay Corporation (NYSE: TK) is estimated to report quarterly loss at $0.08 per share on revenue of $296.76 million.
    KEMET Corporation (NYSE: KEM) is projected to report quarterly earnings at $0.41 per share on revenue of $306.72 million.
    Vascular Biogenics Ltd. (NASDAQ: VBLT) is estimated to report a quarterly loss at $0.21 per share.
    Teekay Offshore Partners L.P. (NYSE: TOO) is expected to report quarterly earnings at $0.04 per share on revenue of $272.04 million.
    Albireo Pharma, Inc. (NASDAQ: ALBO) is expected to report quarterly earnings at $1.77 per share on revenue of $31.32 million.

     

  • [By Adam Levine-Weinberg]

    On Monday, top department store stocks including Macy’s (NYSE:M), Kohl’s (NYSE:KSS), Dillard’s (NYSE:DDS), and J.C. Penney (NYSE:JCP) lost roughly 3% to 4%. The catalyst was a negative analyst report.

  • [By Shane Hupp]

    Wall Street brokerages predict that Dillard’s (NYSE:DDS) will post earnings of ($0.52) per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Dillard’s’ earnings, with the highest EPS estimate coming in at ($0.31) and the lowest estimate coming in at ($0.72). Dillard’s posted earnings of ($0.58) per share during the same quarter last year, which would suggest a positive year over year growth rate of 10.3%. The firm is scheduled to issue its next earnings results on Thursday, August 9th.

Top 5 Undervalued Stocks To Own For 2019: America’s Car-Mart Inc.(CRMT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of America's Car-Mart, Inc. (NASDAQ: CRMT) got a boost, shooting up 15 percent to $62.65 after reporting upbeat Q4 results.

    Precipio, Inc. (NASDAQ: PRPO) shares were also up, gaining 23 percent to $0.5150 after the nano-cap specialty diagnostics company said it saw an acceleration of sales in its Pathology services in April. The company now expects to see a sequential double digit quarterly sales growth.

  • [By Joseph Griffin]

    America’s Car-Mart, Inc. (NASDAQ:CRMT) – Research analysts at Jefferies Group cut their Q1 2019 earnings per share (EPS) estimates for America’s Car-Mart in a research note issued on Tuesday, May 22nd. Jefferies Group analyst J. Hecht now expects that the company will post earnings of $1.08 per share for the quarter, down from their previous forecast of $1.21. Jefferies Group also issued estimates for America’s Car-Mart’s Q3 2019 earnings at $0.75 EPS, FY2019 earnings at $4.40 EPS, Q2 2020 earnings at $0.96 EPS, Q3 2020 earnings at $0.95 EPS and FY2020 earnings at $5.10 EPS.

  • [By Dan Caplinger]

    Tuesday was down day on Wall Street, with major benchmarks losing a quarter percent or more. Market participants spent a lot of time watching the geopolitical situation, where a planned meeting between leaders of North Korea and the U.S. ran into possible hurdles. Yet there wasn’t a really big response in some of the financial markets, with oil staying close to the $72-per-barrel mark and 10-year Treasury yields remaining above 3%. Some individual companies had good news that sent their shares higher, however. Micron Technology (NASDAQ:MU), Eldorado Gold (NYSE:EGO), and America’s Car-Mart (NASDAQ:CRMT) were among the best performers on the day. Here’s why they did so well.

  • [By Lisa Levin]

    Shares of America's Car-Mart, Inc. (NASDAQ: CRMT) got a boost, shooting up 17 percent to $63.76 after reporting upbeat Q4 results.

    Precipio, Inc. (NASDAQ: PRPO) shares were also up, gaining 18 percent to $0.4944 after the nano-cap specialty diagnostics company said it saw an acceleration of sales in its Pathology services in April. The company now expects to see a sequential double digit quarterly sales growth.

  • [By Lisa Levin] Gainers
    Forward Pharma A/S (NASDAQ: FWP) shares gained 88.18 percent to close at $4.14 on Tuesday.
    Regional Health Properties, Inc. (NYSE: RHE) shares jumped 18.04 percent to close at $0.3010 on Tuesday.
    Precipio, Inc. (NASDAQ: PRPO) shares gained 16.61 percent to close at $0.49 after the nano-cap specialty diagnostics company said it saw an acceleration of sales in its Pathology services in April. The company now expects to see a sequential double digit quarterly sales growth.
    Arcturus Therapeutics Ltd. (NASDAQ: ARCT) rose 16.09 percent to close at $7.00 on Tuesday.
    America's Car-Mart, Inc. (NASDAQ: CRMT) gained 14.53 percent to close at $62.65 after reporting upbeat Q4 results.
    NanoString Technologies, Inc. (NASDAQ: NSTG) shares surged 12.64 percent to close at $13.19.
    Geron Corporation (NASDAQ: GERN) gained 12.12 percent to close at $4.07 on Tuesday.
    Quotient Limited (NASDAQ: QTNT) shares climbed 11.58 percent to close at $6.55 on Tuesday.
    American Equity Investment Life Holding Company (NYSE: AEL) rose 11.23 percent to close at $32.28 following a report from Reuters that the company is looking for a sale.
    iQIYI, Inc. (NASDAQ: IQ) gained 11.15 percent to close at $22.52.
    Veracyte, Inc. (NASDAQ: VCYT) rose 10.4 percent to close at $7.11.
    Stein Mart, Inc. (NASDAQ: SMRT) gained 10.26 percent to close at $3.33. Stein Mart is expected to release quarterly earnings on May 23.
    MiMedx Group, Inc. (NASDAQ: MDXG) shares rose 10.11 percent to close at $8.06.
    The Container Store Group, Inc. (NYSE: TCS) gained 8.2 percent to close at $8.18. Container Store reported weaker-than-expected earnings for its fourth quarter after the closing bell.
    Photronics, Inc. (NASDAQ: PLAB) shares gained 7.69 percent to close at $9.10 after the company reported upbeat Q2 results.
    Micron Technology, Inc. (NASDAQ: MU) rose 6.4 percent to close at $59.03 after reporting a $10 billion buyback plan.

     

  • [By Garrett Baldwin]

    Markets have been under pressure once again by the U.S. Federal Reserve. Inflation levels are going through the roof… but the people in charge of managing it have been lying to Americans for years. Now, it’s time to get even.Money MorningLiquidity Specialist Lee Adler has the perfect way to make a lot of money when no one is looking.Read it here.

    The Top Stock Market Stories for Monday
    Markets are cheering news that the supposed trade war between the United States and China is “on hold,” according to U.S. Treasury Secretary Steven Mnuchin. Mnuchin and U.S. President Donald Trump’s top economic advisor, Larry Kudlow, announced that both nations have reached an agreement, one that established a framework to help address ongoing trade imbalances between the two countries. The prices of crude oil is in focus after Venezuelan President Nicolas Maduro won reelection over the weekend. The election featured a very low turnout and a very large outcry that the vote was rigged. Maduro has a 75% disapproval rating and has been the face of the OPEC member’s widespread mismanagement and economic collapse. Prior to the election, a member of the Trump administration said that the United States would not recognize the authenticity of the election. The United States is considering additional sanctions on Venezuela. Today is a major day for mergers and acquisition activity. Today, Blackstone Group LP(NYSE: BX) announced plans to purchase U.S. hotel operator LaSalle Hotel Properties (NYSE: LHO) for a whopping $3.7 billion. The deal comes at a time that the travel industry is experiencing one of the best periods in a decade. If you’re looking for a way to make money ahead of Memorial Day weekend, we show you how here.
    Four Stocks to Watch Today: GOOGL, GE, MBFI, FITB
    Alphabet Inc. (Nasdaq: GOOGL) is under pressure this morning after a harsh piece aired last night on “60 Minutes.” The segment discussed the organization’s power and influence. It also featured inter

Top 5 Undervalued Stocks To Own For 2019: TerraForm Power, Inc.(TERP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Three high-yield options that fit that mold areBrookfield Infrastructure Partners (NYSE:BIP), TerraForm Power (NASDAQ:TERP), and Crestwood Equity Partners (NYSE:CEQP). However, while that income with upside alone makes them ideal ones to buy for the long haul, each has a particular catalyst on the horizon that makes them especially compelling right now.

  • [By Travis Hoium]

    Renewable energy has quietly become one of the best places for investors to find high-quality dividends that sport high yields as well. Yieldcos likeBrookfield Renewable Partners (NYSE:BEP), TerraForm Power (NASDAQ:TERP), Pattern Energy (NASDAQ:PEGI), and NRG Yield (NYSE:NYLD) (NYSE:NYLD-A)have yields of over 5% along with long-term contracted cash flows to sell energy to utilities.

  • [By Ethan Ryder]

    TerraForm Power Inc (NASDAQ:TERP) has been assigned a consensus recommendation of “Hold” from the nine analysts that are presently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $13.80.

  • [By Logan Wallace]

    BidaskClub lowered shares of TerraForm Power (NASDAQ:TERP) from a hold rating to a sell rating in a report issued on Friday morning.

    A number of other brokerages have also recently commented on TERP. Goldman Sachs cut TerraForm Power from a neutral rating to a sell rating in a report on Thursday, March 15th. Zacks Investment Research raised TerraForm Power from a hold rating to a strong-buy rating and set a $13.00 target price on the stock in a report on Tuesday, May 8th. ValuEngine raised TerraForm Power from a sell rating to a hold rating in a report on Thursday, May 3rd. JPMorgan Chase raised TerraForm Power from a neutral rating to an overweight rating and set a $13.00 target price on the stock in a report on Thursday, May 3rd. Finally, Royal Bank of Canada began coverage on TerraForm Power in a report on Wednesday, April 4th. They issued an outperform rating and a $13.00 target price on the stock. Three equities research analysts have rated the stock with a sell rating, one has given a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company has a consensus rating of Hold and an average price target of $13.67.

Hot Cheap Stocks To Buy Right Now

When Damien Maguire moved to the countryside outside Dublin, he struggled to keep the lights on at home because of the town’s constant power outages. He found a solution inside his electric cars: their batteries.

A tinkerer who posts videos of his hand-built vehicles on Youtube, Maguire devised a wiring system that lets him suck power out of them when they’re parked in the garage. Now that the house and cars are connected, he can also use the batteries to store energy from his backyard solar panels, another power source that’s not totally reliable given Ireland’s weather.

“You have the light-bulb moment,” said the 41-year-old electrical engineer. “There’s a big battery in the car, so how about I use that?”

An even bigger light-bulb moment is happening for utilities and automakers, who want to use the batteries inside electric cars as storage for the entire public power grid. The idea, known as “vehicle-to-grid,” is to someday have millions of drivers become mini electricity traders, charging up when rates are cheap and pumping energy back into the grid during peak hours or when the sun simply isn’t shining. If it works — and it’s a big if — renewable energy could get much cheaper and more widely used.

Hot Cheap Stocks To Buy Right Now: Regeneron Pharmaceuticals, Inc.(REGN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    QCI Asset Management Inc. NY bought a new stake in shares of Regeneron (NASDAQ:REGN) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 39,620 shares of the biopharmaceutical company’s stock, valued at approximately $13,644,000.

  • [By Joseph Griffin]

    UBS Group upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN) from a market perform rating to an outperform rating in a research report sent to investors on Wednesday, thefly.com reports.

  • [By Cory Renauer]

    Attention bargain shoppers: There could be some deals in aisle biotech.Agenus Inc.(NASDAQ:AGEN)andRegeneron Pharmaceuticals (NASDAQ:REGN) dished out some disappointing losses in recent months, but the market’s reaction to recent events seems a bit overdone.

  • [By Cory Renauer]

    Amgen’s next-generation cholesterol drug, Repatha has finally started marching upwards in recent quarters, but it could stall out in the quarters ahead. One of America’s largest pharmacy benefits managers recently dropped Repathain favor of a rival therapy from Regeneron (NASDAQ:REGN) andSanofi (NYSE:SNY). That puts a lot of strain on the only other younger products generating significant sales growth right now.

  • [By Jon C. Ogg]

    Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) had very positive late-stage trial data for the treatment of RA back in 2016. The company’s Phase 3 monotherapy study in conjunction with Sanofi met its primary endpoint, demonstrating that sarilumab was superior to adalimumab (marketed by AbbVie as Humira) in improving signs and symptoms in patients with active RA. The drug is now known as Kevzara.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Friday was Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) which rose about 7.5% to $310.61. The stocks 52-week range is $281.89 to $543.55. Volume was 2.8 million compared to the daily average volume of nearly 1 million.

Hot Cheap Stocks To Buy Right Now: Advanced Energy Industries, Inc.(AEIS)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Park Avenue Institutional Advisers LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Park+Avenue+Institutional+Advisers+LLC

    These are the top 5 holdings of Park Avenue Institutional Advisers LLCAMC Entertainment Holdings Inc (AMC) – 60,000 shares, 25.7% of the total portfolio. A V Homes Inc (AVHI) – 35,000 shares, 19.79% of the total portfolio. Wynn Resorts Ltd (WYNN) – 3,000 shares, 16.68% of the total portfolio. Shares reduced by 28.57%Advanced Energy Industries Inc (AEIS) – 8,230 shares, 16.04% of the total portfolio. New PositionAMC Networks Inc (AMCX) – 9,000 shares, 14.18% of the t

  • [By Max Byerly]

    Principal Financial Group Inc. raised its stake in Advanced Energy (NASDAQ:AEIS) by 0.9% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 651,524 shares of the electronics maker’s stock after buying an additional 5,673 shares during the quarter. Principal Financial Group Inc. owned approximately 1.66% of Advanced Energy worth $41,632,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Advanced Energy (NASDAQ:AEIS) has received an average rating of “Hold” from the eight research firms that are presently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, three have given a hold recommendation and three have given a buy recommendation to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $78.20.

Hot Cheap Stocks To Buy Right Now: Aqua America, Inc.(WTR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Aqua America (NYSE:WTR) from a hold rating to a buy rating in a report released on Friday.

    Several other analysts also recently weighed in on the stock. Zacks Investment Research upgraded shares of Aqua America from a hold rating to a buy rating and set a $41.00 price objective on the stock in a research report on Monday, January 15th. Wells Fargo downgraded shares of Aqua America from an outperform rating to a market perform rating and dropped their price target for the stock from $43.00 to $37.00 in a research report on Monday, February 26th. UBS began coverage on shares of Aqua America in a research report on Thursday, March 8th. They set a neutral rating and a $36.00 price target on the stock. Finally, Boenning Scattergood restated a neutral rating on shares of Aqua America in a research report on Tuesday, April 24th. Seven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus target price of $38.29.

  • [By ]

    Cramer was bearish on United States Steel (X) , Teva Pharmaceuticals (TEVA) , Aqua America (WTR) and Mueller Water Products (MWA) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Logan Wallace]

    Lord Abbett & CO. LLC reduced its holdings in shares of Aqua America Inc (NYSE:WTR) by 89.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 68,700 shares of the utilities provider’s stock after selling 565,954 shares during the quarter. Lord Abbett & CO. LLC’s holdings in Aqua America were worth $2,340,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Joseph Griffin]

    Aqua America (NYSE: WTR) and SJW Group (NYSE:SJW) are both utilities companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

  • [By Ethan Ryder]

    Connecticut Water Service (NASDAQ: CTWS) and Aqua America (NYSE:WTR) are both utilities companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation.

Best Safest Stocks To Buy Right Now

Nordea (OTCPK:NRBAY) is, for those unfamiliar, the biggest pan-Nordic banking group, having market shares of 15-30% in each of the four Nordic countries: Denmark, Finland, Norway, and Sweden. According to Global Financial Magazine, Nordea was ranked as the 29th safest bank globally in 2017. The ranking was based on the long-term foreign currency ratings issued by Fitch Ratings, Standard & Poor’s and Moody’s Investors Service.

Source: Company data

Another indicator of its safe-haven status is the fact that Nordeas junior subordinated bonds, or the so-called CoCos, are trading at just a 3.4% yield. For comparison, JPMorgans (JPM) CoCos are trading at a 5.5% yield.

Best Safest Stocks To Buy Right Now: Plains All American Pipeline L.P.(PAA)

Advisors’ Opinion:

  • [By Dustin Parrett]

    We think Plains All American Pipeline L.P. (NYSE: PAA) is one of the best oil stocks to buy this year. In fact, we see a scenario where PAA stock could jump 20% in 2017.

  • [By Dustin Parrett]

    Plains All American Pipeline (NYSE: PAA) controls 4 million barrels of crude oil and natural gas a day.

    And with higher oil prices and fewer restrictions leading to more drilling, PAA’s pipelines will be in demand in 2017.

  • [By Matthew DiLallo]

    One of the largest projects is the Saddlehorn Pipeline, which Magellan is building with Plains All American Pipeline (NYSE:PAA) and Anadarko Petroleum (NYSE:APC). Both Plains All American Pipeline and Magellan own 40% of the project, which puts their total investment at $230 million apiece. They expect the project to be fully operational early next year, which is noteworthy given its robust first-year economics. Magellan estimates that it will earn eight times EBITDA on the capital deployed, or roughly $28.8 million in annual EBITDA apiece for Magellan and Plains All American Pipeline on their investment.

Best Safest Stocks To Buy Right Now: Digirad Corporation(DRAD)

Advisors’ Opinion:

  • [By ]

    Some of these are even smaller nano-caps, such as medical device maker Digirad (Nasdaq: DRAD), whose entire market value is just $36 million.

    There is absolutely nothing wrong with small businesses. I own shares of quite a few in my personal account. But for the most part, I use them to fill out the growth sleeve of my portfolio and don’t consider them stable income producers.

Best Safest Stocks To Buy Right Now: Regeneron Pharmaceuticals, Inc.(REGN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Regeneron Pharmaceuticals (REGN) soared to the top of the S&P 500 today after a competitor’s competing drug failed a Phase 3 trial.

    Getty Images

    Regenerongained 3.8% to $387.10 today, while the S&P 500 declined 0.1% to 2,256.96.

    RBC’s Adnan Butt and Michael Yee offer their take:

    Two Phase 3 studies comparing Ophthotechs (OPHT) Fovista plus Lucentis to Lucentis alone did not meet the primary endpoint of demonstrating a better vision for the combination at 12 months. The improvements were 10.24 letters for the combo vs. 10.01 for Lucentis when the two Phase 3s were combined. Individually, one Phase 3 showed combo improvement of 10.74 letters vs. 9.82 letters alone and the second 9.91 letters vs. 10.36 letters with Lucentis alone. A third Phase 3 study combining Fovista with Eylea or Avastin is ongoing…

    Big overhang removed; [Regeneron] shares should be up and then continue to rise with the focus moving to dupilumab. Overhang was that Fovista success and approval could disrupt the market for Eylea as more docs tried combining nearly free Avastin (off-label) with Fovista to improve outcomes with patients. We had always argued that even under that scenario Eylea would be used since it is the most potent agent. We are buyers at current level especially ahead of the upcoming dupilumab launch.

    Regeneron’s market capitalization rose to $51.5 billion today from $39.3 billion yesterday. It reported net income of $636 million on sales of $4.1 billion in 2015.

  • [By Todd Campbell, Demitrios Kalogeropoulos, and Reuben Gregg Brewer]

    In the case of these three stocks, however, it may be worth taking a gamble. Our contributors think catalysts at Regeneron Pharmaceuticals (NASDAQ:REGN), Royal Dutch Shell (NYSE:RDS-B), and United Parcel Service (NYSE:UPS) can get them back to their winning ways. Read on to find out if these down-and-out stocks are right for your portfolio.

  • [By WWW.THESTREET.COM]

    That’s why Cramer said he’ll be listening for news coming from Celgene (CEL) , Amgen (AMGN) , Allergan (AGN) , an Action Alerts PLUS holding, and Regenron (REGN) , all of which are set to present. Of the four, Cramer said he’s sticking with Allergan and Amgen.

  • [By Chris Lange]

    Shares of Amgen Inc. (NASDAQ: AMGN) saw a handy gain to close out the week after the company won a Delaware court ruling that blocked Sanofi (NYSE: SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) from selling their cholesterol-lowering drug in the United States. Essentially the court found that the drug Praluent actually infringed upon Amgens patents for its rival treatment Repatha.

Best Safest Stocks To Buy Right Now: Tantech Holdings Ltd.(TANH)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggestedshorting small cap China based carbon stock Tantech Holdings Ltd (NASDAQ: TANH):

    “The downtrend here is crystal clear; more of the same weakness is there on the earlier part of the chart you can’t see. What’s so compelling about the selloff is yesterday’s bar. The bulls tried to bounce back, but couldn’t… the buyers threw in the towel. TANH peeled back to close closer to the low than the high, and is following through — to the downside — today.”

Best Safest Stocks To Buy Right Now: Atara Biotherapeutics, Inc.(ATRA)

Advisors’ Opinion:

  • [By Chris Lange]

    Atara Biotherapeutics Inc. (NASDAQ: ATRA) shares surged on Friday after the firm announced that it received clearance from the U.S. Food and Drug Administration (FDA) to initiate two Phase 3 clinical studies. Specifically these mid-stage studies deal with tabelecleucel in patients with rituximab-refractory Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+PTLD).

Best Safest Stocks To Buy Right Now: Francesca's Holdings Corporation(FRAN)

Advisors’ Opinion:

  • [By Lisa Levin] Related LOV Match Group And Spark Networks: A Valentine's Day Case Study 20 Biggest Mid-Day Losers For Thursday
    Related VKTX 15 Biggest Mid-Day Losers For Tuesday 18 Biggest Mid-Day Losers For Wednesday Companies Reporting Before The Bell
    Canadian Solar Inc. (NASDAQ: CSIQ) is expected to report its quarterly earnings at $0.32 per share on revenue of $690.27 million.
    General Mills, Inc. (NYSE: GIS) is projected to report its quarterly earnings at $0.71 per share on revenue of $3.84 billion.
    Coca-Cola European Partners Plc (NYSE: CCE) is estimated to report its quarterly earnings at $0.45 per share on revenue of $2.72 billion.
    Lands' End, Inc. (NASDAQ: LE) is expected to report its quarterly earnings at $0.35 per share on revenue of $459.43 million.
    Francesca's Holdings Corp (NASDAQ: FRAN) is estimated to report its quarterly earnings at $0.37 per share on revenue of $145.91 million.
    Cheetah Mobile Inc (ADR) (NYSE: CMCM) is projected to report its quarterly earnings at $0.06 per share on revenue of $178.04 million.
    Neogen Corporation (NASDAQ: NEOG) is estimated to report its quarterly earnings at $0.27 per share on revenue of $90.05 million.
    Lennar Corporation (NYSE: LEN) is projected to post earnings for its first quarter.
    Fifth Street Asset Management Inc (NASDAQ: FSAM) is expected to report its quarterly earnings at $0.14 per share on revenue of $25.12 million.

     

  • [By Lisa Levin]

    Francesca's Holdings Corporation (NASDAQ: FRAN) was down, falling around 9 percent to $7.09 following downbeat quarterly earnings.

    Commodities

  • [By Paul Ausick]

    Francesca’s Holdings Corp. (NASDAQ: FRAN) dropped about 4.5% Monday to post a 52-week low of $5.68 after closing at $5.95 on Friday. The 52-week high is $19.50. Volume was around 2.7 million, more than double the daily average. The specialty retailer lowered its fourth-quarter outlook last Friday and the investor walkaway continues.

  • [By Ben Levisohn]

    Francesca’s Holdings (FRAN) has jumped 5.4% to $11.00 after beating earnings forecasts.

    Restoration Hardware (RH) has tumbled 20% to $28.92 after slashing its full-year guidance. Restoration Hardware was also cut to Market Perform from Outperform at Telsey Advisory Group.

stock market today chart

This morning, we added small cap mobile communication equipment and content stock KVH Industries, Inc (NASDAQ: KVHI) to our Elite Opportunity Pro (EOP) portfolio as the Company iswell positioned for industrial mobile connectivity growth over land and sea. KVH Industries is a leading provider of in-motion satellite TV and communications systems, having designed, manufactured, and sold more than 200,000 mobile satellite antennas for applications on vessels, vehicles and aircraft. The Company is also a leading news, music, and entertainment content provider to many industries including maritime, retail and leisure. In addition, Videotel (a KVH company) is a market-leading provider of training films, computer-based training and eLearning.

On the fundamental side, our EOP newsletter noted:

stock market today chart: U.S. Bancorp(USB)

Advisors’ Opinion:

  • [By John Maxfield]

    One of this era’s most successful bankers has decided to relinquish the reins. U.S. Bancorp (NYSE:USB) announced on Tuesday that chairman and CEO Richard Davis will step down from his role as CEO at the bank’s annual meeting in April. He’ll stay on as executive chairman of the board, while President and COO Andy Cecere will succeed him in the corner office.

  • [By Sarfaraz Khan]

    In addition to this, Warren Buffett has also built sizable positions in a number of major US banks.Wells Fargo (NYSE:WFC), U.S. Bancorp (NYSE:USB)and Goldman Sachs (NYSE:GS)have the leading positions in Berkshire Hathaways portfolio. In fact, Wells Fargo is Berkshire Hathaway’s second largest stock holding. In addition to this, Berkshire Hathaway also owns $5 billion worth of Bank of Americas preferred shares and warrants to buy 700 million of the banks ordinary shares at just $7.14 (current price $22.10) anytime until September 2021. These banks are positioned to become the biggest beneficiaries of the increase in interest rates. To get an idea of how this might happen, consider Bank of Americas forecast in which it predicted a $7.5 billion boost to annual net interest income following a 1-percentage-point increase in interest rates.

stock market today chart: CarMax Inc(KMX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    CarMax (KMX) gained 2.4% to $58 after beating earnings and sales forecasts.

    Constellation Brands (STZ) has rallied 4.7% to $169 after beating earnings forecasts and offering optimistic guidance.

  • [By Lisa Levin]

    CarMax, Inc (NYSE: KMX) reported better-than-expected earnings for its fourth quarter.

    CarMax reported Q4 earnings of $0.81 per share on revenue of $4.05 billion. Analysts expected earnings of $0.79 per share on revenue of $3.93 billion.

  • [By Craig Jones]

    Jon Najarian spoke about high options activity in CarMax, Inc (NYSE: KMX). He said traders are buying upside calls, the 75 strike calls and higher. Jon Najarian decided to buy calls in the name and he's planning to hold them for 10 days.

  • [By Ben Levisohn]

    Yesterday, I dubbed the selloff in auto stocks “car-pocalypse now,” as shares of everything car related tumbled following disappointing auto sales. Shares of General Motors (GM) and Ford Motor (F)? Check. Auto-part makers like BorgWarner (BWA)? Check. Used-car sellers like AutoNation (AN) and CarMax (KMX)? Check. Auto-part retailers like O’Reilly Automotive (ORLY) and AutoZone (AZO)? Oh yeah. So is it time to panic?

stock market today chart: iShares Core S&P Mid-Cap (IJH)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Lubar & Co., Inc’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Lubar+%26+Co.%2C+Inc

    These are the top 5 holdings of Lubar & Co., IncEnLink Midstream LLC (ENLC) – 1,882,007 shares, 37.97% of the total portfolio. Shares added by 0.40%Hallador Energy Co (HNRG) – 2,788,685 shares, 23.23% of the total portfolio. Vanguard Value ETF – DNQ (VTV) – 77,126 shares, 7.65% of the total portfolio. iShares Core S&P Mid-Cap (IJH) – 38,400 shares, 6.84% of the total portfolio. New PositionVanguard Mid-Cap Value ETF – DNQ (VOE) – 61,550 shares, 6.52% of the tota

stock market today chart: Ellie Mae, Inc.(ELLI)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Ellie Mae (ELLI) was downgraded to sector perform from outperform at RBC Capital. $90 price target. The company is leveraged to lower expected refinance activity, RBC said. 

  • [By Brian Stoffel]

    For a long time, low rates were a huge boon to Ellie Mae (NYSE:ELLI), which offers subscribers access to the Encompass platform. Encompass helps streamline the mortgage origination process.

  • [By Jason Hall, Brian Stoffel, and Brian Feroldi]

    With that idea in mind, we asked three of our top contributors to write about a stock they see as being a bargain today, and they gave us mortgage industry software lynchpinEllie Mae Inc(NYSE:ELLI), real estate holding companyStore Capital Corp(NYSE:STOR), and steelmaker extraordinaireNucor Corporation(NYSE:NUE).

  • [By Jason Moser]

     Not intimidated by the Fed’s 25-basis-point rate hike in December, Jason chose Ellie Mae (ELLI), a company with a leading cloud productthat facilitates and streamlines the mortgage originations process.

    “Its primary offering, Encompass, is a cloud-based one-stop shop for mortgage originators, allowing them to manage the loan process from start to finish,” Moser says. And by streamlining the process, Ellie Mae’s Encompass “increases efficiency and loan quality, reduces documentation errors, and helps keep everyone out of regulatory trouble.”

    With trailing revenues just below $250 million, Moser pegs the market opportunity as a $5 billion pie, and thinks ELLI will prove to be one of the best stocks to buy for 2016.

  • [By Lee Jackson]

    These companies also reported insider selling last week:Corcept Therapeutics Inc. (NASDAQ: CORT), Customers Bancorp Inc. (NYSE: CUBI), Ellie Mae Inc. (NYSE: ELLI), Fiserv Inc. (NASDAQ: FISV) and Ulta Beauty Inc. (NASDAQ: ULTA).

  • [By Brian Stoffel]

    HR and payroll specialist Paycom Software (NYSE:PAYC), mortgage software provider Ellie Mae (NYSE:ELLI), and cloud computing king for drug companies Veeva Systems (NYSE:VEEV) are the three best software companies you could buy in 2017. They share three key traits that any investor can love: high switching costs, blazing growth rates, and founders or CEOs with lots of skin in the game.

stock market today chart: Regeneron Pharmaceuticals, Inc.(REGN)

Advisors’ Opinion:

  • [By Chris Lange]

    Shares of Amgen Inc. (NASDAQ: AMGN) saw a handy gain to close out the week after the company won a Delaware court ruling that blocked Sanofi (NYSE: SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) from selling their cholesterol-lowering drug in the United States. Essentially the court found that the drug Praluent actually infringed upon Amgens patents for its rival treatment Repatha.

  • [By Ben Levisohn]

    Regeneron Pharmaceuticals (REGN) tumbled to the bottom of the S&P 500 today after a judge said the company could be forced to stop selling an anti-cholesterol drug due to violating an Amgen (AMGN) patent.

    Agence France-Presse/Getty Images

    Regeneron Pharmaceuticalsdropped 5.8% to $358.68 today, while the S&P 500 rose 0.4% to 2,276.98.

    Chardan’sGbola Amusa takes a victory lap:

    Yesterday, after markets closed, it was announced that US Federal District Court Judge Sue Robinson ruled to issue a permanent injunction against Praluent, the PCSK9 mAb for hypercholesterolemia from partners Regeneron and Sanofi, due to infringement of patents from Amgen. The court has imposed a 30-day suspension (stay) on the injunction to allow for settlement or appeal of the District Court decision. Sanofi and Regeneron have announced their intent to appeal the ruling to the US Court of Appeals for the Federal Circuit (CAFC). The injunction decision is consistent with our counter-consensus published views communicated on 25 January 2016 (“Downgrade to Sell on evidence of likely infringement of Amgen’s PCSK9 patents”) and subsequently. Based on consultation with expert legal counsel, we now put >75% probability Amgen will prevail on appeal and/or Praluent is ultimately removed from the US market, and/or Amgen achieves a settlement substantially in its favor. We currently model $3.3 bn in non-risk-adjusted 2022E US revenues for Praluent, while consensus models $1.2 bn in 2022E US revenues. We reiterate our view from 25 January 2016 to preferentially own Amgen, The Medicines Company (MDCO) (Buy), and Alnylam (ALNY) (Buy) over Regeneron for exposure to PCSK9 inhibitor market dynamics as outcomes trials approach.

    While the loss is bad news for Regeneron, Barron’s Johanna Bennettargues that it could herald a comeback for Amgen.

    Regeneron’s market capitalization fell to $38.5 billion today from $40.2 bil

  • [By Ben Levisohn]

    After years of rising and falling in tandem, the biotech sector is all about stock picking now. Credit Suisse analyst Alethia Young and team, for instance, upgraded Regeneron Pharmaceuticals (REGN), and added Celgene (CELG) to its Focus List today. But Amgen (AMGN) wasn’t so lucky as Young cut it to Neutral from Outperform. She explains why:

  • [By Ben Levisohn]

    Regeneron Pharmaceuticals (REGN) soared to the top of the S&P 500 today after a competitor’s competing drug failed a Phase 3 trial.

    Getty Images

    Regenerongained 3.8% to $387.10 today, while the S&P 500 declined 0.1% to 2,256.96.

    RBC’s Adnan Butt and Michael Yee offer their take:

    Two Phase 3 studies comparing Ophthotechs (OPHT) Fovista plus Lucentis to Lucentis alone did not meet the primary endpoint of demonstrating a better vision for the combination at 12 months. The improvements were 10.24 letters for the combo vs. 10.01 for Lucentis when the two Phase 3s were combined. Individually, one Phase 3 showed combo improvement of 10.74 letters vs. 9.82 letters alone and the second 9.91 letters vs. 10.36 letters with Lucentis alone. A third Phase 3 study combining Fovista with Eylea or Avastin is ongoing…

    Big overhang removed; [Regeneron] shares should be up and then continue to rise with the focus moving to dupilumab. Overhang was that Fovista success and approval could disrupt the market for Eylea as more docs tried combining nearly free Avastin (off-label) with Fovista to improve outcomes with patients. We had always argued that even under that scenario Eylea would be used since it is the most potent agent. We are buyers at current level especially ahead of the upcoming dupilumab launch.

    Regeneron’s market capitalization rose to $51.5 billion today from $39.3 billion yesterday. It reported net income of $636 million on sales of $4.1 billion in 2015.